Two Sigma Investments’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-727,923
Closed -$19.7M 3410
2024
Q2
$19.7M Sell
727,923
-70,061
-9% -$1.46M 0.04% 464
2024
Q1
$14.6M Buy
797,984
+210,141
+36% +$3.33M 0.03% 533
2023
Q4
$7.21M Buy
587,843
+199,669
+51% +$1.87M 0.02% 816
2023
Q3
$5.82M Buy
388,174
+139,301
+56% +$2.9M 0.02% 818
2023
Q2
$8.09M Sell
248,873
-34,903
-12% -$1.27M 0.02% 723
2023
Q1
$11.1M Buy
283,776
+208,746
+278% +$10.2M 0.03% 553
2022
Q4
$3.97M Buy
+75,030
New +$3.65M 0.01% 964
2021
Q3
Sell
-95,945
Closed -$4.59M 4840
2021
Q2
$4.59M Sell
95,945
-199,615
-68% -$10.2M 0.01% 1255
2021
Q1
$15M Buy
295,560
+250,046
+549% +$13.9M 0.04% 538
2020
Q4
$2.87M Buy
45,514
+27,614
+154% +$1.71M 0.01% 1265
2020
Q3
$1.2M Sell
17,900
-35,522
-66% -$1.94M ﹤0.01% 1639
2020
Q2
$2.24M Buy
+53,422
New +$2.05M 0.01% 1042

Other funds holding SILK

Two Sigma Investments's SILK Position: Q3 2024 in Review

Two Sigma Investments sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 727,923 shares — an estimated $19.7M sold.

Two Sigma Investments first reported a position in SILK in Q2 2020 and held it in 12 quarters. The position peaked at $19.7M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Two Sigma Investments reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Investments sold 727,923 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $19.7M.
  • Two Sigma Investments first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • Two Sigma Investments's Silk Road Medical, Inc. Common Stock position peaked at $19.7M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.